How many clinical trials are studying NMDAE?

7 recruiting trials in our tracked data involve NMDAE.

What conditions is NMDAE being studied for?

In our tracked recruiting trials, NMDAE is being studied in trials for Schizophrenia, Depression, Major Depressive Disorder.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 7

Condition	Trials
Schizophrenia · NMDAE for Schizophrenia	4
Depression · NMDAE for Depression	3
Major Depressive Disorder	2
Bipolar I Disorder	1
Bipolar disorder	1
Prodromal Schizophrenia	1

Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
NCT05052853 · Phase: Phase 2 · Ages: 13 Years to 45 Years · Sex: All (male and female) · 1 location
Monotherapy of an NMDA Enhancer for Schizophrenia
NCT04745143 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
NCT05136755 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
NMDA Modulation in Major Depressive Disorder
NCT04637620 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
NCT05977023 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
NCT06021197 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
NCT07122895 · Phase: Phase 2 · Ages: 20 Years to 65 Years · Sex: All (male and female) · 1 location